Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy

Guardado en:

Detalles Bibliográficos
Autores principales:	Junyu Long, Xu Yang, Jin Bian, Dongxu Wang, Anqiang Wang, Yu Lin, Mingjun Zheng, Haohai Zhang, Xinting Sang, Haitao Zhao
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/96b6a2e1ce744fbab61316cd9a77ffd1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:96b6a2e1ce744fbab61316cd9a77ffd1
record_format	dspace
spelling	oai:doaj.org-article:96b6a2e1ce744fbab61316cd9a77ffd12021-11-30T07:25:38ZIdentification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy2001-132610.1002/ctm2.598https://doaj.org/article/96b6a2e1ce744fbab61316cd9a77ffd12021-11-01T00:00:00Zhttps://doi.org/10.1002/ctm2.598https://doaj.org/toc/2001-1326Junyu LongXu YangJin BianDongxu WangAnqiang WangYu LinMingjun ZhengHaohai ZhangXinting SangHaitao ZhaoWileyarticleMedicine (General)R5-920ENClinical and Translational Medicine, Vol 11, Iss 11, Pp n/a-n/a (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Junyu Long Xu Yang Jin Bian Dongxu Wang Anqiang Wang Yu Lin Mingjun Zheng Haohai Zhang Xinting Sang Haitao Zhao Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy
format	article
author	Junyu Long Xu Yang Jin Bian Dongxu Wang Anqiang Wang Yu Lin Mingjun Zheng Haohai Zhang Xinting Sang Haitao Zhao
author_facet	Junyu Long Xu Yang Jin Bian Dongxu Wang Anqiang Wang Yu Lin Mingjun Zheng Haohai Zhang Xinting Sang Haitao Zhao
author_sort	Junyu Long
title	Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy
title_short	Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy
title_full	Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy
title_fullStr	Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy
title_full_unstemmed	Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy
title_sort	identification of tmb, cd8 t‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐pd‐1/pd‐l1 therapy
publisher	Wiley
publishDate	2021
url	https://doaj.org/article/96b6a2e1ce744fbab61316cd9a77ffd1
work_keys_str_mv	AT junyulong identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT xuyang identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT jinbian identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT dongxuwang identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT anqiangwang identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT yulin identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT mingjunzheng identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT haohaizhang identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT xintingsang identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT haitaozhao identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy
_version_	1718406764545703936

Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy

Ejemplares similares